Candriam S.C.A. - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 159 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2020. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2020$3,566,000
-40.5%
95,955
-17.8%
0.03%
-47.6%
Q2 2020$5,993,000
-52.2%
116,804
-45.7%
0.06%
-54.7%
Q1 2020$12,538,000
-2.2%
215,0960.0%0.14%
+1.5%
Q4 2019$12,826,000
+863.6%
215,096
+617.0%
0.14%
+661.1%
Q3 2018$1,331,000
+13.2%
30,0000.0%0.02%
-5.3%
Q2 2018$1,176,000
-45.8%
30,0000.0%0.02%
-48.6%
Q1 2018$2,170,000
-61.2%
30,000
-64.7%
0.04%
-61.9%
Q4 2017$5,596,000
+39.6%
85,000
+6.2%
0.10%
+38.6%
Q3 2017$4,010,000
+23.8%
80,000
+14.3%
0.07%
+14.8%
Q2 2017$3,240,000
+367.5%
70,000
+40.0%
0.06%
+258.8%
Q3 2016$693,000
+40.3%
50,0000.0%0.02%
+30.8%
Q2 2016$494,000
-54.1%
50,000
-21.9%
0.01%
-51.9%
Q1 2016$1,076,000
-35.6%
64,000
-14.7%
0.03%
-40.0%
Q4 2015$1,670,000
-29.8%
75,000
-25.6%
0.04%
-22.4%
Q3 2015$2,378,000
-81.8%
100,800
-37.0%
0.06%
-78.7%
Q2 2015$13,082,000
-1.2%
160,000
+11.9%
0.27%
+1.9%
Q1 2015$13,245,000
+495.5%
143,000
+160.0%
0.27%
+480.4%
Q4 2014$2,224,00055,0000.05%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q4 2020
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$20,735,0008.65%
Altium Capital Management LP 2,496,524$11,584,0003.88%
Deep Track Capital, LP 6,000,000$27,840,0001.78%
Paradigm Biocapital Advisors LP 1,157,246$5,370,0001.42%
Monaco Asset Management SAM 419,262$1,945,0000.77%
Rhenman & Partners Asset Management AB 981,582$4,555,0000.45%
PLATINUM INVESTMENT MANAGEMENT LTD 2,713,176$12,589,0000.39%
Bellevue Group AG 4,299,164$19,948,0000.23%
WASATCH ADVISORS LP 8,147,380$37,804,0000.19%
Telemetry Investments, L.L.C. 17,500$81,0000.13%
View complete list of ESPERION THERAPEUTICS INC NE shareholders